English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Chiu-Ching Huang1, Che Yi Chou1, Chin Lin Chou2, Joseph Kao1, Chiz Tzung Chang1 and Chao Jung Chen2,3 for Urothelial Carcinoma Study Consortium, Taiwan 1China Medical University and Hospitals, Kidney Institute, Taichung, TAIWAN, 2China Medical University, Proteomics Core Laboratory, Department of Medical Research, Taichung, TAIWAN, 3China Medical University, Graduate Institute of Integrated Medicine, Taichung, TAIWAN.

FP252CKD PATIENTS WHO DEVELOPED UROTHELIAL CARCINOMA HAVE HIGHER URINARY CONCENTRATIONS OF PHTHALATE METABOLITES - A PRELIMINARY STUDY FROM TAIWAN